David Restaino Fox Rothschild LLP
Results 1 to 5 of 20
FDA seeks public comment on questions related to drug and biological product shortages *
USA - February 13 2013
Pursuant to the Food and Drug Administration Safety and Innovation Act (FDASIA) signed into law on July 9, 2012, the Food and Drug Administration…
Co-authors: Shahnam Sharareh, PharmD, RAC.
State's "more stringent" Stark Law restrictions upheld by court *
USA - January 30 2013
Today I am focusing on the self-referral ban under the federal Stark laws. In particular, a recent case - Fresenius Medical Care Holdings, Inc. v…
Green groups clash with business over NJ enviro waivers *
USA - January 18 2013
A New Jersey appellate court is set to determine the fate of a controversial measure by the state's environmental regulator to waive land use…
OIG announces 2013 priorities *
USA - January 3 2013
Now that the new year is upon us, today's post will look at the Department of Health and Human Services' Office of Inspector General (OIG), in particular…
Encouraging in-house disclosures in a whistleblower's world *
USA - December 28 2012
Compliance officials have a great deal to worry about. They are judged by results and loaded with stress over the latest changes in government guidance…
Co-authors of David Restaino
Other Fox Rothschild LLP authors
- Aaron D. Weems,
- Cheryl A. Garber,
- Christina A. Stoneburner,
- Christopher R. Kinkade,
- Derald J. Hay,
- Eleanor Vaida Gerhards ,
- Eliana Baer,
- Eric S. Solotoff ,
- Ernest E. Badway,
- Gregory B. Williams,
- Jennifer Weisberg Millner,
- Jonathan D. Ash,
- Joshua Horn ,
- Lauren E. Koster,
- Michael J. Viscount, Jr.,
- Richard B. Cohen,
- Robert A. Epstein,
- Samuel W. Cortes,
- Scott M. Badami,
- Todd A. Palo
